Darifenacin Hydrobromide extended Release IP 7.5
Nov 02, 2022
Derifenac 7.5
Darifenacin Hydrobromide extended Release IP 7.5 is used to treat an overactive bladder. By relaxing the muscles in the bladder, Darifenacin Hydrobromide extended Release IP 7.5 improves your ability to control your urination. Darifenacin Hydrobromide extended Release IP 7.5 helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom.
For more information please contact:
Recent Post
Voglibose 0.3 mg: Uses, Benefits, Dosage, Side Effects & Precautions
Glimepiride Voglibose and Metformin Tablets – Uses & Benefits
Voglibose and Metformin Hydrochloride Tablets – Uses & Benefits
Voglibose 0.3 mg + Metformin SR 500 mg: Uses & Benefits
Voglibose 0.2mg: Uses, Benefits, Dosage & Side Effects
VOGLISLOW G3 M 0.3: Uses, Benefits & Side Effects
Valganciclovir Tablet IP 450 mg: Uses, Benefits, Dosage, Side Effects
Vonoprazan 10 mg: for Acid Reflux and GERD
Vonoprazan 20 mg: Uses, Benefits, Dosage, Side Effects
Ondansetron 4 mg Orally Disintegrating Tablets IP – Uses, Benefits & Precautions